1. Home
  2. PRO vs BBNX Comparison

PRO vs BBNX Comparison

Compare PRO & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRO
  • BBNX
  • Stock Information
  • Founded
  • PRO 1985
  • BBNX 2015
  • Country
  • PRO United States
  • BBNX United States
  • Employees
  • PRO N/A
  • BBNX N/A
  • Industry
  • PRO EDP Services
  • BBNX Medical/Dental Instruments
  • Sector
  • PRO Technology
  • BBNX Health Care
  • Exchange
  • PRO Nasdaq
  • BBNX Nasdaq
  • Market Cap
  • PRO 898.3M
  • BBNX 463.4M
  • IPO Year
  • PRO 2007
  • BBNX 2025
  • Fundamental
  • Price
  • PRO $16.06
  • BBNX $11.14
  • Analyst Decision
  • PRO Strong Buy
  • BBNX Strong Buy
  • Analyst Count
  • PRO 10
  • BBNX 6
  • Target Price
  • PRO $31.10
  • BBNX $26.67
  • AVG Volume (30 Days)
  • PRO 552.9K
  • BBNX 693.2K
  • Earning Date
  • PRO 05-01-2025
  • BBNX 05-06-2025
  • Dividend Yield
  • PRO N/A
  • BBNX N/A
  • EPS Growth
  • PRO N/A
  • BBNX N/A
  • EPS
  • PRO N/A
  • BBNX N/A
  • Revenue
  • PRO $330,372,000.00
  • BBNX $65,123,999.00
  • Revenue This Year
  • PRO $10.12
  • BBNX $29.49
  • Revenue Next Year
  • PRO $10.10
  • BBNX $34.93
  • P/E Ratio
  • PRO N/A
  • BBNX N/A
  • Revenue Growth
  • PRO 8.78
  • BBNX 442.93
  • 52 Week Low
  • PRO $14.81
  • BBNX $8.89
  • 52 Week High
  • PRO $34.71
  • BBNX $24.50
  • Technical
  • Relative Strength Index (RSI)
  • PRO 31.97
  • BBNX N/A
  • Support Level
  • PRO $15.65
  • BBNX N/A
  • Resistance Level
  • PRO $16.86
  • BBNX N/A
  • Average True Range (ATR)
  • PRO 0.87
  • BBNX 0.00
  • MACD
  • PRO 0.01
  • BBNX 0.00
  • Stochastic Oscillator
  • PRO 26.37
  • BBNX 0.00

About PRO PROS Holdings Inc.

Pros Holdings Inc. is a provider of cloud-based revenue and profit realization software solutions to business-to-business and business-to-consumer companies. Its solutions assist customers in growing revenue, modernizing business processes, and supporting profitability by leveraging prescriptive analytics and data science-based decision-making technology. The company's solutions enable buyers to move fluidly across its customers' direct sales, partner, online, mobile, and emerging channels with personalized experiences. The firm generates revenue in the United States, Europe, Africa, Asia-Pacific, and Middle East regions.

About BBNX Beta Bionics Inc. Common Stock

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: